Serum and urinary metabolomics and outcomes in cirrhosis.

by Jasmohan S Bajaj, Sili Fan, Leroy R Thacker, Andrew Fagan, Edith Gavis, Melanie B White, Douglas M Heuman, Michael Fuchs, Oliver Fiehn
Published 2019-01-01

Region 11 MELD Na exception prospective study

by Robert A. Fisher, Douglas M. Heuman, Ann M. Harper, Martha K. Behnke, Alastair D. Smith, Mark W. Russo, Steven Zacks, John W. McGillicuddy, James Eason, Michael K. Porayko, Patrick Northup, Michael R. Marvin, Johnathan Hundley, Satheesh Nair
Published 2012-01-01

Modulation of the metabiome by rifaximin in patients with cirrhosis and minimal hepatic encephalopathy.

by Jasmohan S Bajaj, Douglas M Heuman, Arun J Sanyal, Phillip B Hylemon, Richard K Sterling, R Todd Stravitz, Michael Fuchs, Jason M Ridlon, Kalyani Daita, Pamela Monteith, Nicole A Noble, Melanie B White, Andmorgan Fisher, Masoumeh Sikaroodi, Huzefa Rangwala, Patrick M Gillevet
Published 2013-01-01